📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

A safety, tolerability and biomarker update from an ongoing open-label extension study of RG6042 in adults with early manifest Huntington's disease (2019)

First Author: Leavitt B

Attributed to: MICA: HD-CSF: Studying cerebrospinal fluid to understand key CNS pathobiological targets in Huntington's disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jns.2019.10.260

Publication URI: http://dx.doi.org/10.1016/j.jns.2019.10.260

Type: Journal Article/Review

Parent Publication: Journal of the Neurological Sciences